Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
IOL Chemicals and Pharmaceuticals Limited
IOLCP | NSE
89.11
INR-3.47
-3.75%
IOLCP | NSE
Loading StockChartView...
About IOL Chemicals and Pharmaceuticals Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
24/04/2026
Close
89.11
Open
92.70
High
93.60
Low
87.50
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API) such as ibuprofen ibuprofen lysinate ibuprofen sodium and dex- ibuprofen; and other APIs including metformin hydrochloride clopidogrel bisulphate pantoprazole sodium ursodeoxycholic acid losartan potassium gabapentin levetiracetam lamotrigine and fenofibrate. Its products are used for treatments which include anti-inflammatory analgesic and antipyretic anti-diabetic anti- platelet anti-cholesterol anti- convulsant anti-cholelithic as well as proton pump inhibitor. The company also provides specialty industrial chemicals comprising ethyl acetate iso butyl benzene acetyl chloride and mono chloro acetic acid for use in food processing flexible packaging pharmaceuticals textiles ink paint pesticides and chemical intermediates industries. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is headquartered in Ludhiana India.
View LessIOLCP | NSE
Risk
53.1
Sharpe
0.74
Luna's Score
48/100
Recommendation
Hold
Luna says (IOLCP | NSE)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
52.7%1 month
53.1%3 months
51.2%6 months
44.6%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
20.75
Fwd. PE
-
Price to book
1.53
Debt to equity
0.02
Debt to assets
0.01
Ent. to EBITDA
10.17
Ent. to rev.
1.16
PEG
-
Other Fundamentals
EBITDA
2.10B
MarketCap
5.28B
MarketCap(USD)
55.32M
Div. yield
1.19
Op. margin
6.83
Erngs. growth
-34.60
Rev. growth
-10.80
Ret. on equity
8.62
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
16.39
Range1M
23.39
Range3M
28.40
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.83
Price X volume
130.61M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 10.17 | 24.85 | Cheaper |
| Ent. to Revenue | 1.16 | 11.40 | Cheaper |
| PE Ratio | 20.75 | 51.36 | Cheaper |
| Price to Book | 1.53 | 6.83 | Cheaper |
| Dividend Yield | 1.19 | 0.52 | Leader |
| Std. Deviation (3M) | 51.21 | 42.17 | Riskier |
| Debt to Equity | 0.02 | 0.35 | Cheaper |
| Debt to Assets | 0.01 | 0.17 | Cheaper |
| Market Cap | 5.28B | 290.82B | Emerging |
